Prevalence of thyroid abnormalities in HIV/AIDS persons and correlation with CD4 count, HAART drug and duration of illness


  • Ayyanagouda A. Gangannavar Department of General Medicine, Koppal Institute of Medical Science, Koppal, Karnataka, India
  • Raghu G. Department of General Medicine, Koppal Institute of Medical Science, Koppal, Karnataka, India
  • Mahendra S. V. Department of General Medicine, Koppal Institute of Medical Science, Koppal, Karnataka, India
  • Manoj Kumar B. K. Department of Medicine, Adichunchanagiri Institute of Medical Science Bellur Cross BG Nagara, Karnataka, India
  • Umesh Rajoor Department of General Medicine, Koppal Institute of Medical Science, Koppal, Karnataka, India



CD4 count, HAART drug, HIV/AIDS persons, Thyroid abnormalities


Background: Human immunodeficiency virus (HIV) infection is characterized by decrease in CD4 cell count and immunodeficiency, leading to opportunistic infections (OIs) and tumors.  Objective of this study was to find out any association between thyroid function abnormality and CD4 count, duration of disease and ART drugs.

Methods: Among 300 HIV/AIDS Persons attending ART centre, M.Y. Hospital, or attending general OPD, or admitted as in patients Dept. of Medicine, MGM Medical College and M.Y. Hospital, Indore, India.

Results: Amongst 300 HIV patients,62 (20.66%) had thyroid dysfunction, most common being subclinical hypothyroidism (24/300, 8.0%) followed by sick euthyroid (17/300, 5.6%) and subclinical hyperthyroidism (13/300, 4.3%). Overt hypothyroidism was present in 5 of 300 (1.66%) patients and overt hyperthyroidism was present in 3 of 300 (1.0%) patients.  25 of 152 (16.44%) and 37 of 148 (25%) male and female HIV patients had thyroid function abnormality. Thyroid dysfunction was significantly more observed in old HIV patients (42/150, 28.0%) than in newly diagnosed HIV patient’s group (20/150, 13.33%).

Conclusions: This prevalence being fairly high, it can be suggested that all retro positive patients, recently diagnosed and on treatment also may be subjected for routine thyroid function testing.


Antiretroviral Therapy Cohort C. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):e349-56.

Bongiovanni M, Adorni F, Casana M, Tordato F, Tincati C, Cicconi P, et al., Subclinical hypothyroidism in HIV-infected subjects. J Antimicro Chemo. 2006;58(5):1086-9.

Madeddu G, Spanu A, Chessa F, Calia GM, Lovigu C, Solinas P, et al. Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study. Clin Endocrinol. 2006;64(4):375-83.

Brockmeyer NH, Kreuter A, Bader A, Seemann U, Reimann G. Prevalence of endocrine dysfunction in HIV infected men. Hormone Res. 2000;54(5):294-5.

Silva GA, Andrade MC, Sugui DD, Nunes RF, Pinto JF, Silva WD et al. Association between antiretrovirals and thyroid diseases: a cross-sectional study. Arch Endocrinol Metabol. 2015;59(2):116-22.

Hoffmann CJ, Brown TT. Thyroid function abnormalities in HIV-infected patients. Clin Inf Dis. 2007;45(4):488-94.

Dobs AS, Dempsey MA, Ladenson PW, Polk BF. Ladenson, and B. F. Polk. Endocrine disorders in men infected with human immunodeficiency virus. Am J Med. 1988;84(3):611-6.

Sellmeyer DE, Grunfeld C. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocrine Rev. 1996;17(5):518-32.

Meena LP, Rai M, Singh SK, Chakravarty J, Singh A, Goel R, et al. Endocrine changes in male HIV patients. J Assoc Physicians India. 2011;59:365‑6.

Grappin M, Piroth L, Verges B, Sgro C, Mack G, Buisson M, B, et al. Increased prevalence of subclinical hypothyroidism in HIV patients treated with highly active antiretroviral therapy. AIDS. 2000;14:1070-2.

Ji S, Jin C, Höxtermann S, Fuchs W, Xie T, Lu X, et al. Prevalence and influencing factors of thyroid dysfunction in HIV-infected patients. BioMed Res Int. 2016 Apr 20;2016.

Harsløf M, Knudsen AD, Benfield T. No evidence of increased risk of thyroid dysfunction in well treated people living with HIV. AIDS. 2018;32(15):2195-9.

Báez MS, Zapata Silva A, López Benavides MI, Wilson G. Thyroid dysfunction among HIV infected patients. Rev Med Chil. 2016 Mar;144(3):333-40.

Sharma N, Sharma LK, Dutta D, Gadpayle AK, Anand A, Gaurav K, et al. Prevalence and Predictors of Thyroid Dysfunction in Patients with HIV Infection and Acquired Immunodeficiency Syndrome: An Indian Perspective. J Thyroid Res. 2015;2015:517173.

Dev N, Sahoo R, Kulshreshtha B, Gadpayle AK, Sharma SC. Prevalence of thyroid dysfunction and its correlation with CD4 count in newly-diagnosed HIV-positive adults--a cross-sectional study. Int J STD AIDS. 2015 Nov;26(13):965-70.

Menon U, Sundaram KR, Unnikrishnan AG, Jayakumar RV, Nair V, Kumar H. High prevalence of undetected thyroid disorders in an iodine sufficient adult south Indian population. J Indian Med Assoc. 2009;107:72-7.






Original Research Articles